CHK1-CDC25A-CDK1 regulate cell cycle progression and protect genome integrity in early mouse embryos

Area of Science:

• Developmental Biology
• Cell Cycle Regulation
• Mammalian Embryogenesis

Background:

• Oocyte and sperm genomes require significant remodeling post-fertilization to achieve totipotency and transcriptional activity in early blastomeres.
• Cell cycle adaptation, including G1 and G2 phase length changes, accompanies this transition, but its regulation in mammals is unclear.
• Checkpoint kinase 1 (CHK1) is a known regulator of cell cycle progression in somatic cells.

Purpose of the Study:

• To investigate the role of CHK1 in regulating cell cycle progression during early mammalian development.
• To elucidate how CHK1 influences genome activation and reprogramming in early mouse embryos.
• To determine the consequences of Chk1 depletion on embryonic genome integrity and fertility.

Main Methods:

• Utilized mouse embryo models to study cell cycle dynamics.
• Investigated the interaction between CHK1, CDK1, and CDC25A.
• Assessed DNA damage, chromosome segregation, and ploidy after Chk1 depletion.

Main Results:

• CHK1 restrains CDK1 activity by promoting CDC25A degradation, thereby regulating cell cycle progression in early mouse embryos.
• CHK1 ensures a prolonged G2 phase essential for genome activation and gene expression reprogramming in two-cell stage embryos.
• Chk1 depletion resulted in significant DNA damage, chromosome segregation errors, aneuploidy, and subsequent infertility.

Conclusions:

• CHK1 plays a critical role in managing cell cycle progression and genome activation during early mouse embryogenesis.
• CHK1 activity is essential for maintaining genomic stability and ensuring successful reproduction in mammals.
• Dysregulation of CHK1 can lead to developmental defects and infertility due to compromised genome integrity.